Cargando…
oxLDL antibody inhibits MCP‐1 release in monocytes/macrophages by regulating Ca(2+)/K(+) channel flow
oxLDL peptide vaccine and its antibody adoptive transferring have shown a significantly preventive or therapeutic effect in atherosclerotic animal model. The molecular mechanism behind this is obscure. Here, we report that oxLDL induces MCP‐1 release in monocytes/macrophages through their TLR‐4 (Tol...
Autores principales: | Su, Jinyu, Zhou, Hui, Liu, Xianyan, Nilsson, Jan, Fredrikson, Gunilla Nordin, Zhao, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387129/ https://www.ncbi.nlm.nih.gov/pubmed/27995732 http://dx.doi.org/10.1111/jcmm.13033 |
Ejemplares similares
-
Elucidation of the Role of Lectin-Like oxLDL Receptor-1 in the Metabolic Responses of Macrophages to Human oxLDL
por: Kimmel, Danielle W., et al.
Publicado: (2017) -
oxLDL and eLDL Induced Membrane Microdomains in Human Macrophages
por: Wallner, Stefan, et al.
Publicado: (2016) -
LOX-1, OxLDL, and Atherosclerosis
por: Pirillo, Angela, et al.
Publicado: (2013) -
Immune modulatory effects of progesterone on oxLDL‐induced trained immunity in monocytes
por: Groh, Laszlo A., et al.
Publicado: (2022) -
LXRα Regulates oxLDL-Induced Trained Immunity in Macrophages
por: Findeisen, Hannes M., et al.
Publicado: (2022)